Cargando…
Risk factors of significant relapse and appropriate maintenance therapy strategy in SLE-associated immune thrombocytopenia
BACKGROUND: Systemic lupus erythematosus–associated immune thrombocytopenia (SLE-ITP) is characterized by relapse. The risk factors of relapse and appropriate maintenance therapy strategy deserve further exploration. OBJECTIVES: To determine the risk factors for relapse and appropriate maintenance t...
Autores principales: | Li, He-Jun, Zheng, Yi-Qing, Chen, Ling, Lin, Shun-Ping, Zheng, Xiang-Xiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031598/ https://www.ncbi.nlm.nih.gov/pubmed/36969501 http://dx.doi.org/10.1177/20406223231160688 |
Ejemplares similares
-
Autoimmune Thrombocytopenia in SLE and COVID-19
por: Pratama, Yeremia Suryo, et al.
Publicado: (2021) -
Chinese SLE Treatment and Research group (CSTAR) registry: Clinical significance of thrombocytopenia in Chinese patients with systemic lupus erythematosus
por: Jiang, N., et al.
Publicado: (2019) -
PB2306: RELAPSE OF IMMUNE THROMBOCYTOPENIA AND MYOCARDITIS
por: Kapsouli, F., et al.
Publicado: (2022) -
Relapse of immune thrombocytopenia after COVID‐19 vaccination
por: van Dijk, Wobke E. M., et al.
Publicado: (2021) -
Frequently Relapsing Post-COVID-19 Immune Thrombocytopenia
por: Serrano, Claudia, et al.
Publicado: (2021)